The inactivated SARS-CoV-2 vaccine (Vero cell) is prepared by inoculating African green monkey kidney cells (Vero cell) with the SARS-CoV-2 HB02 strain, culturing, harvesting, inactivating, clarifying, concentrating, purifying, and adding aluminum hydroxide adjuvant.

After inoculating the vaccine, the recipients can produce an immune response to prevent diseases caused by SARS-CoV-2.

3,000  persons between 18 and 85 years old will participate in this trial.